British Columbia-based ImmunoPrecise Antibodies (IPA) will relocate its laboratories to a new biotech Centre of Excellence at the Pivot Park Campus in Oss, the Netherlands. With its new space at Pivot Park, ImmunoPrecise will house next-generation equipment to support its workforce, in addition to expanding its European operations and advancing innovative research & development for its antibody technology.
“We are very excited to advance our ambitions driving our valuable innovation-driven antibody discovery, selection, engineering, and manufacturing capabilities in our new state-of-the-art facility,” said Dr. Debby Kruijsen, General Manager of IPA Europe. “We are confident that this expansion enables us to meet the growing interest in IPA’s custom antibody solutions and R&D activities.”
Read more here
